Repaglinide is a fast-acting insulin secretagogue that stimulates insulin release by binding to β-cell KATP channels. It is used in diabetes research focusing on glucose-dependent insulin secretion and β-cell physiology. Repaglinide is valuable for evaluating drug–channel interactions and postprandial glucose control. It also helps explore pancreatic β-cell signaling dynamics.
Keywords
Repaglinide; Prandin; AG-EE624ZW
Citations
Publication ()
Have you cited DAG-ZL1938 in a publication? Let us know and earn a reward for your research.
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.